Quantcast
Last updated on April 21, 2014 at 5:01 EDT

Latest Lateral flow test Stories

2011-09-22 07:45:00

LANSING, Mich., Sept. 22, 2011 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) has developed a quick and easy new test for aflatoxin, a toxin considered by many to be the most potent, naturally-occurring carcinogen. The toxin is a by-product of mold growth in a wide range of commodities, including corn. Because it is a known severe threat to human and animal health, more than 100 countries have established regulatory limits for aflatoxin in commodities intended as human food or animal...

2009-12-17 06:00:00

UNION CITY, Calif., Dec. 17 /PRNewswire-FirstCall/ -- Abaxis, Inc. (Nasdaq: ABAX), a medical products company manufacturing point-of-care blood analysis instruments and rapid tests for the medical, research and veterinary markets, announced today that it has entered the production animal diagnostics marketplace with its first product, a rapid Avian Influenza Antigen Test. This is a USDA-licensed test for Avian Influenza Type A nucleoprotein antigen in chickens, turkeys and ducks. The...

2008-08-07 12:01:26

WALTHAM, Mass., Aug. 7 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. , a leading provider of near-patient diagnostics, monitoring and health management solutions, has announced the introduction of its new 4th generation rapid HIV diagnostic test, the Determine HIV-1/2 Ag/Ab Combo, at the International AIDS conference (AIDS 2008) in Mexico City. The test will be introduced to the developing world during the third quarter, and in certain other markets during 2009. What...

2008-07-10 09:01:29

Vacci-Test Corporation ("Vacci-Test") is pleased to announce that its French subsidiary, Vacci-Test Europe ("VTE"), has launched its first human diagnostic test, VACCI-TEST(TM) -Tetanus in France and Germany. The product is being distributed by Groupe ServioBio, one of Europe's largest distributors of point-of-care diagnostic tests to hospitals and emergency clinics. VACCI-TEST(TM) -Tetanus is a rapid, sensitive, lateral flow diagnostic assay that determines the immune status of an...

2007-02-15 12:00:13

NEW YORK, Feb. 15 /PRNewswire/ -- As the global call for increased usage of near-patient diagnostic testing escalates, the market for lateral flow point-of-care (LF-POC) tests for everything from cardiac markers and cholesterol to diabetes and infectious diseases continues to rise at a healthy rate, with sales expected to surpass $2.7 billion by 2010, according to Lateral Flow Technology and the Future of Point of Care Diagnostics, a new study from medical market research firm Kalorama...